These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2076751)

  • 1. Converting enzyme inhibition in isolated porcine resistance artery potentiates bradykinin relaxation.
    Félétou M; Teisseire B
    Eur J Pharmacol; 1990 Nov; 190(1-2):159-66. PubMed ID: 2076751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Converting-enzyme inhibitors potentiate bradykinin-induced relaxation in vitro.
    Félétou M; Germain M; Teisseire B
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H839-45. PubMed ID: 1558194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-(1-7) augments endothelium-dependent relaxations of porcine coronary arteries to bradykinin by inhibiting angiotensin-converting enzyme 1.
    Raffai G; Khang G; Vanhoutte PM
    J Cardiovasc Pharmacol; 2014 May; 63(5):453-60. PubMed ID: 24390175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists.
    Meyer P; Flammer J; Lüscher TF
    Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):555-62. PubMed ID: 7890486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different effects of angiotensin-converting enzyme inhibition in human arteries and veins.
    Yang Z; Arnet U; von Segesser L; Siebenmann R; Turina M; Lüscher TF
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S17-22. PubMed ID: 7508047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin-converting enzyme inhibitors on resistance artery structure and endothelium-dependent relaxation in two-kidney, one-clip Goldblatt hypertensive and sham-operated rats.
    Bennett MA; Thurston H
    Clin Sci (Lond); 1996 Jan; 90(1):21-9. PubMed ID: 8697701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibition on arterial, venous and capillary functions in cat skeletal muscle in vivo.
    Ekelund U
    Acta Physiol Scand; 1996 Sep; 158(1):29-37. PubMed ID: 8876745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart and vascular wall as targets for tissue converting enzyme inhibition.
    Schölkens BA; Linz W; Han YF
    Clin Exp Hypertens A; 1987; 9(2-3):427-33. PubMed ID: 3038406
    [No Abstract]   [Full Text] [Related]  

  • 9. Endothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: enhancement by exercise-training.
    Mombouli JV; Nakashima M; Hamra M; Vanhoutte PM
    Br J Pharmacol; 1996 Feb; 117(3):413-418. PubMed ID: 8821528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiorphan enhances bradykinin-induced vascular relaxation in hypoxic/hyperkalaemic porcine coronary artery.
    Krassói I; Pataricza J; Papp JG
    J Pharm Pharmacol; 2003 Mar; 55(3):339-45. PubMed ID: 12724039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide modulates captopril-mediated angiotensin-converting enzyme inhibition in porcine iliac arteries.
    Persson K; Andersson RG
    Eur J Pharmacol; 1999 Nov; 385(1):21-7. PubMed ID: 10594341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endothelium and vascular effects of the ACE inhibitor trandolaprilat.
    Vidal M; Joly G; Mombouli JV; Boulanger CM; Vanhoutte PM
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S1-5. PubMed ID: 7527094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors: role of endothelium-derived kinins.
    Hecker M; Bara AT; Busse R
    J Vasc Res; 1993; 30(5):257-62. PubMed ID: 8399986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
    Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme-independent contraction to angiotensin I in human resistance arteries.
    Padmanabhan N; Jardine AG; McGrath JC; Connell JM
    Circulation; 1999 Jun; 99(22):2914-20. PubMed ID: 10359736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bradykinin and angiotensin II inhibit neurotransmission in rabbit ear artery by releasing prostanoids.
    Rónai AZ
    Eur J Pharmacol; 1991 May; 198(1):93-5. PubMed ID: 1655480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
    Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G
    Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturation of the response to bradykinin in resistance and conduit pulmonary arteries.
    Boels PJ; Deutsch J; Gao B; Haworth SG
    Cardiovasc Res; 1999 Nov; 44(2):416-28. PubMed ID: 10690318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries.
    Nakashima M; Mombouli JV; Taylor AA; Vanhoutte PM
    J Clin Invest; 1993 Dec; 92(6):2867-71. PubMed ID: 8254041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the new angiotensin-I-converting enzyme inhibitor imidapril on the responses of isolated vascular preparations to various agonists.
    Kubo M; Fujitsuka T; Ishida R
    Arzneimittelforschung; 1992 Apr; 42(4):446-51. PubMed ID: 1642667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.